Fact CheckerSign in

NCT06594055Completed

Periodic Use of Continuous Glucose Monitoring With Personalized Diet Interventions Using AI Camera Among Non-insulin Treated Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 7 Mar 2025

Brief summary (registry, in English)

The aim of this study is to evaluate the periodic use of continuous glucose monitoring (CGM) with an AI camera and following diet education among non-insulin-treated type 2 diabetes patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
120 (actual)
First submitted
10 Sept 2024
Start date
4 Apr 2023
Primary completion date
31 Oct 2024
Lead sponsor
Kangbuk Samsung Hospital
NCT number
NCT06594055

What you commit to

  • Study type: Interventional
  • Participants enrolled: 120
  • From 4 Apr 2023 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those who have used steroids within the past 3 months or are expected to use them during the study period (excluding ointments)
  • Patients who have undergone pancreatic resection

Other illness

  • Type 1 diabetes patients

Lab values

  • Those deemed by the researcher to have difficulty handling continuous glucose monitors and AI cameras

Other

  • Insulin users
  • Patients undergoing hemodialysis or peritoneal dialysis
  • Those requiring continuous MRI and CT scans
  • Those deemed unsuitable for participation in this clinical trial by the investigator, other than those mentioned above
  • Pregnant women

Who the study is looking for

  • Type 2 diabetes patients
  • HbA1c 6.5% - 10%
  • No medication changes in the past 3 months, and receiving treatment with lifestyle modification or oral antidiabetic drugs or GLP-1 receptor agonists
  • Ages 18 - 80 years old

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kangbuksamsung Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.